Non-parametric quantification of protein lysate arrays

Bioinformatics

Volumn 23, Issue 15, 2007, Pages 1986-1994

  Hu, Jianhua ^a   He, Xuming ^b   Baggerly, Keith A ^a   Coombes, Kevin R ^a   Hennessy, Bryan T J ^a   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN HYDROLYSATE;

ARTICLE; DATA ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; RELIABILITY; SIMULATION; SYSTEMATIC ERROR;

EID: 34548141874     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btm283     Document Type: Article

References (40)

1. Amit,I. et al. (2006) A module of negative feedback regulators defines growth factor signaling. Nat. Genet., 39, 503-512.
2. Beran,R. (1986) Simulated power functions. Ann. Stat., 14, 151-173.
3. Bernard,K.R. et al. (2004) Methods in functional proteomics: two-dimensional polyacrylamide gel electrophoresis with immobilized PH gradients, in-gel digestion and identification of proteins by mass spectrometry. Method Mol. Biol., 250, 263-282.
4. Cahill,D.J. and Nordhoff,E. (2003) Protein arrays and their role in proteomics. Adv. Biochem. Eng. Biotechnol., 83, 177-187.
5. Camp,R.L. et al. (2000) Validation of tissue microarray technology in breast carcinoma. Lab. Invest., 80, 1943-1949.
6. Chan,S.M. et al. (2004) Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med., 10, 1390-1396.
7. Cheng,K.W. et al. (2005) Assay of Rab25 function in ovarian and breast cancers. Method Enzymol., 403, 202-215.
8. Dudek,H. et al. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-663.
9. Espina,V. et al. (2003) Protein microarrays: Molecular profiling technologies for clinical specimens. Proteomics, 3, 2091-2100.
10. Espina,V. et al. (2004) Protein microarray detection strategies: focus on direct detection technologies. J. Immunol. Methods, 290, 121-133.
11. He,X. and Ng,P. (1999) COBS: Qualitatively constrained smoothing via linear program. Comput. Stat., 14, 315-337.
12. He,X and Shi,P.D. (1998) Monotone B-spline smoothing. J. Am. Stat. Assoc., 93, 643-650.
13. Herrmann,P.C. et al. (2003) Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3, 1801-1810.
14. Hojlund,K. et al. (2003) Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J. Biol. Chem., 278, 10436-10442.
15. Ivanov,S.S. et al. (2004) Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol. Cell Proteomics, 3, 788-795.
16. Jiang,R. et al. (2006) Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics, 2964-2971.
17. Kakizawa,H. et al. (2004) The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism, 53, 350-555.
18. Koenker,R. and Park,B.J. (1994) An interior point algorithm for nonlinear quantile regression. J. Econom., 71, 265-283.
19. Kononen,J. et al. (1998) Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat. Med., 4, 844-847.
20. Lin,Y. et al. (2003) Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin. Chem. Lab. Med., 41, 139-145.
21. Liu,C. et al. (2002) Software tools for high-throughput analysis and archiving of immunohi-stochemistry staining data obtained with tissue microarrays. Am. J. Pathol., 161, 1557-1565.
22. MacBeath,G. (2002) Protein microarrays and proteomics. Nat. Genet. 32, 526-532.
23. MacBeath,G. and Schreiber,S.L. (2000) Printing proteins as microarrays for high-throughput function determination. Science, 289, 1760-1763.
24. Mircean,C. et al. (2005) Robust estimation of protein expression ratios with lysate microarray technology. Bioinformatics, 21 1935-1942.
25. Murph,M.M. et al. (2006) Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the P13K pathway for specific patients. In Ovarian Cancer: State of the Art and Future Directions in Translational Research, Coukos,G. Springer Verlag.
26. Nishizuka,S. et al. (2003a) Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA, 100, 14229-14234.
27. Nishizuka,S. et al. (2003b) Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic proteomic and tissue array profiling. Cancer Res., 63, 5243-5250.
28. Ong,S.E. et al. (2003) Mass spectrometrio-based approaches in quantitative proteomics. Methods, 29, 124-430.
29. Packeisen,J. et al. (2003) Demystified ... tissue microarray technology. Mol. Pathol., 56, 198-204.
30. Paweletz,C.P. et al. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene, 20, 1981-1989.
31. Ramaswamy,A. et al. (2005) -Application of protein laysate microarrays to molecular marker verification and quantification. Proteome Sci., 3, 9.
32. Schweizer,J. et al. (2006) New consensus nomenclature for mammalian keratins. J. Cell. Biol., 174, 169-174.
33. Sheehan,K.M. et al. (2005) Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics, 4, 346-355.
34. Tabus,I. et al. (2006) Nonlinear modeling of protein expressions in protein arrays. IEEE Trans. Signal Processing, 54, 2394-2407.
35. Tibes,R. et al. (2006) Reverse phase protein array (RPPA): Validation of a novel proteomic technology and utility for analysis of primary leukemia specimens. and hematopoetic stem cells (HSC). Mol. Cancer. Ther., 5, 2512-2521.
36. Toney,J.H. et al. (2003) A 'mix and read' assay for insulin, using fluorometric microvolume assay technology. Assay Drug Dev. Technol. 1, 521-525.
37. Torhorst,J. et al. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am. J. Pathol., 159 2249-2256.
38. Wulfkuhle,J.D. et al. (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics, 3, 2085-2090.
39. Yan,F. et al. (2003) Protein microarrays using liquid phase fractionation of cell lysates. Proteomics, 3, 1228-1235.
40. Zha,H. et al. (2004) Similarities of prosurvival signal in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest., 84, 235-244.